Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner.

Myronovych A, Kirby M, Ryan KK, Zhang W, Jha P, Setchell KD, Dexheimer PJ, Aronow B, Seeley RJ, Kohli R.

Obesity (Silver Spring). 2014 Feb;22(2):390-400. doi: 10.1002/oby.20548. Epub 2013 Sep 5.

2.

The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice.

Myronovych A, Salazar-Gonzalez RM, Ryan KK, Miles L, Zhang W, Jha P, Wang L, Setchell KD, Seeley RJ, Kohli R.

Obesity (Silver Spring). 2014 Nov;22(11):2301-11. doi: 10.1002/oby.20890.

3.

TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice.

McGavigan AK, Garibay D, Henseler ZM, Chen J, Bettaieb A, Haj FG, Ley RE, Chouinard ML, Cummings BP.

Gut. 2017 Feb;66(2):226-234. doi: 10.1136/gutjnl-2015-309871. Epub 2015 Oct 28.

4.

Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion.

Stefater MA, Sandoval DA, Chambers AP, Wilson-Pérez HE, Hofmann SM, Jandacek R, Tso P, Woods SC, Seeley RJ.

Gastroenterology. 2011 Sep;141(3):939-949.e1-4. doi: 10.1053/j.gastro.2011.05.008. Epub 2011 May 18.

5.

Vertical sleeve gastrectomy improves indices of metabolic disease in rodent model of surgical menopause.

Lawson WJ, Shirey K, Spann RA, Zamarripa CA, Hosler JP, Grayson BE.

Menopause. 2017 Apr;24(4):426-436. doi: 10.1097/GME.0000000000000764.

6.

IFN-γ secretion in gut of Ob/Ob mice after vertical sleeve gastrectomy and its function in weight loss mechanism.

Du JP, Wang G, Hu CJ, Wang QB, Li HQ, Xia WF, Shuai XM, Tao KX, Wang GB, Xia ZF.

J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):377-82. doi: 10.1007/s11596-016-1595-6. Epub 2016 Jul 5.

PMID:
27376807
7.

H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Raveendran VV, Kassel KM, Smith DD, Luyendyk JP, Williams KJ, Cherian R, Reed GA, Flynn CA, Csanaky IL, Lickteig AL, Pratt-Hyatt MJ, Klaassen CD, Dileepan KN.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G219-28. doi: 10.1152/ajpgi.00027.2014. Epub 2014 May 22.

8.

Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity.

Wang Q, Perrard XD, Perrard JL, Mansoori A, Raya JL, Hoogeveen R, Smith CW, Ballantyne CM, Wu H.

Atherosclerosis. 2011 Nov;219(1):100-8. doi: 10.1016/j.atherosclerosis.2011.07.025. Epub 2011 Jul 21.

9.

Lipocalin-type prostaglandin D2 synthase (L-PGDS) modulates beneficial metabolic effects of vertical sleeve gastrectomy.

Kumar S, Lau R, Hall CE, Palaia T, Rideout DA, Brathwaite CE, Ragolia L.

Surg Obes Relat Dis. 2016 Sep - Oct;12(8):1523-1531. doi: 10.1016/j.soard.2016.04.007. Epub 2016 Apr 7.

PMID:
27425837
10.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
11.

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery.

Kohli R, Setchell KD, Kirby M, Myronovych A, Ryan KK, Ibrahim SH, Berger J, Smith K, Toure M, Woods SC, Seeley RJ.

Endocrinology. 2013 Jul;154(7):2341-51. doi: 10.1210/en.2012-2069. Epub 2013 Apr 16.

12.

Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.

Liu J, Han L, Zhu L, Yu Y.

Lipids Health Dis. 2016 Feb 11;15:27. doi: 10.1186/s12944-016-0194-7.

13.

Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.

Ma Y, Huang Y, Yan L, Gao M, Liu D.

Pharm Res. 2013 May;30(5):1447-57. doi: 10.1007/s11095-013-0986-7. Epub 2013 Feb 1.

14.

Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression.

Zhao LY, Xu JY, Shi Z, Englert NA, Zhang SY.

Biochem Pharmacol. 2017 Oct 15;142:194-203. doi: 10.1016/j.bcp.2017.07.019. Epub 2017 Jul 27.

PMID:
28756207
15.

Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?

Kohli R, Myronovych A, Tan BK, Salazar-Gonzalez RM, Miles L, Zhang W, Oehrle M, Sandoval DA, Ryan KK, Seeley RJ, Setchell KD.

Dig Dis. 2015;33(3):440-6. doi: 10.1159/000371699. Epub 2015 May 27. Review.

PMID:
26045281
16.

Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice.

Ding L, Sousa KM, Jin L, Dong B, Kim BW, Ramirez R, Xiao Z, Gu Y, Yang Q, Wang J, Yu D, Pigazzi A, Schones D, Yang L, Moore D, Wang Z, Huang W.

Hepatology. 2016 Sep;64(3):760-73. doi: 10.1002/hep.28689. Epub 2016 Jul 25.

17.

Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity.

Stefater MA, Pérez-Tilve D, Chambers AP, Wilson-Pérez HE, Sandoval DA, Berger J, Toure M, Tschöp M, Woods SC, Seeley RJ.

Gastroenterology. 2010 Jun;138(7):2426-36, 2436.e1-3. doi: 10.1053/j.gastro.2010.02.059. Epub 2010 Mar 10.

18.

FXR is a molecular target for the effects of vertical sleeve gastrectomy.

Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Pérez HE, Sandoval DA, Kohli R, Bäckhed F, Seeley RJ.

Nature. 2014 May 8;509(7499):183-8. doi: 10.1038/nature13135. Epub 2014 Mar 26.

19.

Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots.

Schneck AS, Iannelli A, Patouraux S, Rousseau D, Bonnafous S, Bailly-Maitre B, Le Thuc O, Rovere C, Panaia-Ferrari P, Anty R, Tran A, Gual P, Gugenheim J.

Surg Endosc. 2014 Feb;28(2):592-602. doi: 10.1007/s00464-013-3211-1. Epub 2013 Oct 3.

PMID:
24196540
20.

Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease.

Gabbi C, Bertolotti M, Anzivino C, Macchioni D, Del Puppo M, Ricchi M, Carubbi F, Tagliafico E, Romagnoli D, Odoardi MR, Loria P, Losi L, Carulli N.

Dig Liver Dis. 2012 Dec;44(12):1018-26. doi: 10.1016/j.dld.2012.07.001. Epub 2012 Aug 9.

PMID:
22883218

Supplemental Content

Support Center